Skip to main content

CNCR

ETF
CNCR · UNKNOWN · 75 holdings

About CNCR

No description available for this ETF.

Fund Details

Expense Ratio
Inception Date
Exchange
UNKNOWN
Currency
USD
Holdings As Of
Apr 10, 2026
Tracked Holdings
88.0%
HHI Score
166.61
Top Sector
Healthcare (61.770767%)

Performance

Moderate (40.8%) → Stabilizing
1W
0.00%
1M
▼ -9.35%
3M
▼ -19.96%
6M
▼ -32.84%
YTD
▼ -26.73%
1Y
▼ -38.13%
3Y
▼ -35.98%

1M loss (-9.35%) is smaller than 3M (-19.96%) — decline may be easing

Concentration Risk

26.85% Balanced
Diversified Concentrated

The top 10 holdings represent 26.85% of the fund. This ETF is well diversified across its holdings, reducing single-stock risk.

Top Holdings Today

Weighted by position size
RXRX
▼ -0.91%
PGEN
▼ -2.58%
CMPX
▼ -5.14%
GNLX
▼ -0.78%
EXEL
▼ -2.51%
DNA
▲ 0.31%
REPL
▼ -19.46%
BMY
▼ -1.43%
SDGR
▼ -0.87%
Weighted avg. of top holdings ▼ -3.37%

Sector Allocation

Healthcare
61.77%
Manufacturing
27.06%

Top 10 Holdings

26.85% of fund
RXRX Recursion Pharmaceuticals Inc
4.01%
PGEN Precigen Inc
3.05%
CMPX Compass Therapeutics Inc
2.99%
GNLX Genelux Corp
2.90%
SWTX SpringWorks Therapeutics Inc
2.86%
EXEL Exelixis Inc
2.48%
DNA Ginkgo Bioworks Holdings Inc
2.33%
REPL Replimune Group Inc
2.14%
BMY Bristol-Myers Squibb Co
2.10%
SDGR Schrodinger Inc/United States
1.98%
Other positions
0.65%

All Holdings (75)

Top 10: 26.85% of fund
# Ticker Name Weight Shares Market Value
1 RXRX Recursion Pharmaceuticals Inc 4.01% 47,707 358,279.57
2 PGEN Precigen Inc 3.05% 157,416 272,329.68
3 CMPX Compass Therapeutics Inc 2.99% 92,038 266,910.2
4 GNLX Genelux Corp 2.90% 61,963 259,005.34
5 SWTX SpringWorks Therapeutics Inc 2.86% 4,426 255,645.76
6 EXEL Exelixis Inc 2.48% 5,730 221,693.7
7 DNA Ginkgo Bioworks Holdings Inc 2.33% 25,263 208,167.12
8 REPL Replimune Group Inc 2.14% 15,047 190,795.96
9 BMY Bristol-Myers Squibb Co 2.10% 3,149 187,743.38
10 SDGR Schrodinger Inc/United States 1.98% 7,925 176,806.75
Showing top 10 of 75 holdings · Listed: 99.35% · 0.65% in other positions

Related ETFs